Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roche Holding Ltd

44.91
+0.24000.54%
Post-market: 44.910.00000.00%16:13 EDT
Volume:1.51M
Turnover:67.84M
Market Cap:286.12B
PE:28.96
High:45.21
Open:44.55
Low:44.50
Close:44.67
52wk High:45.94
52wk Low:34.10
Shares:6.37B
Float Shares:6.37B
Volume Ratio:1.11
T/O Rate:0.02%
Dividend:1.53
Dividend Rate:3.40%
EPS(TTM):1.55
EPS(LYR):2.14
ROE:31.32%
ROA:13.30%
PB:7.92
PE(LYR):21.02

Loading ...

Company Profile

Company Name:
Roche Holding Ltd
Exchange:
OTCQX
Establishment Date:
1896
Employees:
103249
Office Location:
Grenzacherstrasse 124,Basel,Basel-Stadt,Switzerland
Zip Code:
4070
Fax:
41 61 691 00 14
Introduction:
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.